Scientific Publications Search Search Author Impact Factor Release Date Research Group Search Sort by RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Order AscDesc Akalin, Altuna Dr. (1) Begay-Müller, Valerie Dr. (1) Beule, Dieter Dr. (1) Birchmeier-Kohler, Carmen Prof. Dr. (1) Blankenstein, Thomas Prof. Dr. (17) Chekulaeva, Marina Dr. (2) Daniel, Peter Prof. Dr. (2) Daumke, Oliver Prof. Dr. (1) Franke, Vedran Dr. (1) Gerhardt, Holger Prof. Dr. (1) Gotthardt, Michael Prof. Dr. (1) Haucke, Volker Professor (1) Heuser, Arnd Dr. (1) Hübner, Norbert Prof. Dr. (1) Janz, Martin Dr. (9) Kammertöns, Thomas Dr. (4) Kempa, Stefan Dr. (1) Kirchner, Marieluise Dr. (1) Kopp, Joachim Dr. (1) Ku, Min-Chi Dr. (1) Kunz, Severine Dr. (1) Landthaler, Markus Prof. Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (2) Lewin, Gary Prof. Dr. (1) Mathas, Stephan Dr. (9) Müller, Thomas Dr. (1) Niendorf, Thoralf Prof. Dr. (1) Ohler, Uwe Prof. Dr. (2) Patone, Giannino Dr. (1) Pezzutto, Antonio Prof. Dr. (2) Poncette, Lucia (1) Poulet, James Prof. Dr. (1) Radke, Michael Dr. (1) Rajewsky, Nikolaus Prof. Dr. (1) Rocks, Oliver Dr. (1) Scheidereit, Claus Prof. Dr. (1) Schmitt, Clemens Prof. Dr. (1) Selbach, Matthias Prof. Dr. (12) Specker, Edgar Dr. (1) von Kries, Jens Peter Dr. (1) Willimsky, Gerald Dr. (5) Woehler, Andrew Dr. (1) Wollert-Wulf, Brigitte (2) Zauber, Henrik Dr. (1) (-) Leutz, Achim Prof. Dr. (1) (-) Lusatis, Simone (1) (-) Uckert, Wolfgang Prof. Dr. (5) 2003 (4) 2004 (1) (-) 2005 (4) (-) 2006 (2) 2007 (2) 2008 (1) 2010 (1) 2011 (2) 2014 (3) 2015 (2) 2016 (2) (-) 2017 (1) 2018 (2) 2020 (1) 2023 (1) (-) Biology of Malignant Lymphomas (2) Genetics and Genomics of Cardiovascular Diseases (2) Integrative Vascular Biology (1) (-) Molecular Immunology and Gene Therapy (5) Molecular Physiology of Somatic Sensation (1) Translational Bioinformatics (1) 7 Results: Active Filter: Leutz, Achim Prof. Dr.Lusatis, SimoneUckert, Wolfgang Prof. Dr.Biology of Malignant LymphomasMolecular Immunology and Gene Therapy200520062017 Sort: Result score Newest to oldest Oldest to newest November 01, 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert February 01, 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken May 20, 2005 / Bioforum Gentherapie mit T-Zellrezeptor modifizierten Zellen W. Uckert T. Blankenstein January 01, 2005 / Canc Res CY15, a malignant histiocytic tumor that is phenotypically similar to immature dendritic cells T. Kammertoens R. Willebrand B. Erdmann L. Li Y. Li B. Engels W. Uckert T. Blankenstein January 01, 2005 / Blood A rapamycin derivative (everolimus) controls proliferation through down-regulation of truncated CCAAT enhancer binding protein beta and NF-kappaB activity in Hodgkin and anaplastic large cell lymphomas F. Jundt N. Raetzel C. Mueller C.F. Calkhoven K. Kley S. Mathas A. Lietz A. Leutz B. Doerken July 01, 2005 / Hum Gene Ther Redirecting human T lymphocytes toward renal cell carcinoma specificity by retroviral transfer of T cell receptor genes B. Engels E. Noessner B. Frankenberger T. Blankenstein D.J. Schendel W. Uckert May 04, 2017 / Nature Tumour ischaemia by interferon-γ resembles physiological blood vessel regression T. Kammertoens C. Friese A. Arina C. Idel D. Briesemeister M. Rothe A. Ivanov A. Szymborska G. Patone S. Kunz D. Sommermeyer B. Engels M. Leisegang A. Textor H.J. Fehling M. Fruttiger M. Lohoff A. Herrmann H. Yu R. Weichselbaum W. Uckert N. Hübner H. Gerhardt D. Beule H. Schreiber T. Blankenstein
November 01, 2006 / Eur J Immunol Designer T cells by T cell receptor replacement D. Sommermeyer J. Neudorfer M. Weinhold M. Leisegang B. Engels E. Noessner M.H. Heemskerk J. Charo D.J. Schendel T. Blankenstein H. Bernhard W. Uckert
February 01, 2006 / Nat Immunol Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma S. Mathas M. Janz F. Hummel M. Hummel B. Wollert-Wulf S. Lusatis I. Anagnostopoulos A. Lietz M. Sigvardsson F. Jundt K. Joehrens K. Bommert H. Stein B. Doerken
May 20, 2005 / Bioforum Gentherapie mit T-Zellrezeptor modifizierten Zellen W. Uckert T. Blankenstein
January 01, 2005 / Canc Res CY15, a malignant histiocytic tumor that is phenotypically similar to immature dendritic cells T. Kammertoens R. Willebrand B. Erdmann L. Li Y. Li B. Engels W. Uckert T. Blankenstein
January 01, 2005 / Blood A rapamycin derivative (everolimus) controls proliferation through down-regulation of truncated CCAAT enhancer binding protein beta and NF-kappaB activity in Hodgkin and anaplastic large cell lymphomas F. Jundt N. Raetzel C. Mueller C.F. Calkhoven K. Kley S. Mathas A. Lietz A. Leutz B. Doerken
July 01, 2005 / Hum Gene Ther Redirecting human T lymphocytes toward renal cell carcinoma specificity by retroviral transfer of T cell receptor genes B. Engels E. Noessner B. Frankenberger T. Blankenstein D.J. Schendel W. Uckert
May 04, 2017 / Nature Tumour ischaemia by interferon-γ resembles physiological blood vessel regression T. Kammertoens C. Friese A. Arina C. Idel D. Briesemeister M. Rothe A. Ivanov A. Szymborska G. Patone S. Kunz D. Sommermeyer B. Engels M. Leisegang A. Textor H.J. Fehling M. Fruttiger M. Lohoff A. Herrmann H. Yu R. Weichselbaum W. Uckert N. Hübner H. Gerhardt D. Beule H. Schreiber T. Blankenstein